相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ESC 2022 guidelines on cardio-oncology in collaboration with the European Hematology Association (EHA), European Society of Therapeutic Radiology and Oncology (ESTRO) and International Cardio-Oncology Society (IC- OS) developed by the Cardio-Oncology Task Force of the European Society of Cardiology (ESC)
Alexander R. Lyon et al.
GIORNALE ITALIANO DI CARDIOLOGIA (2023)
High-sensitivity cardiac troponins in pediatric population
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann et al.
EUROPEAN HEART JOURNAL (2022)
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis
Alberto Aimo et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Transdermal measurement of cardiac troponins: the future is now
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)
The intra-individual variation of cardiac troponin I: the effects of sex, age, climatic season, and time between samples
Gus Koerbin et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)
Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease
Anqi Li et al.
CELL DEATH & DISEASE (2022)
High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain
Yader Sandoval et al.
CIRCULATION (2022)
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers
Kristin M. Aakre et al.
CLINICAL CHEMISTRY (2022)
Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers. A consensus document by the Inter-Society Study Group on Cardiac Biomarkers of the Italian Societies of Clinical Biochemistry: European Ligand Assay Society (ELAS), Italian section; Societa Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC); Societa Italiana di Patologia Clinica e Medicina di Laboratorio (SIPMel)
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)
A dry chemistry-based ultrasensitive electrochemiluminescence immunosensor for sample-to-answer detection of Cardiac Troponin I
Tingting Zhan et al.
BIOSENSORS & BIOELECTRONICS (2022)
Cardiac biomarkers in the field of cardio-oncology
Daniela Cardinale et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2022)
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
Alexander R. Lyon et al.
EUROPEAN HEART JOURNAL (2022)
Development and preliminary validation of infrared spectroscopic device for transdermal assessment of elevated cardiac troponin
Jitto Titus et al.
COMMUNICATIONS MEDICINE (2022)
The role of mitochondrial dynamics in cardiovascular diseases
Maurizio Forte et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Cardiotoxic effects and myocardial injury: the search for a more precise definition of drug cardiotoxicity
Daniela Maria Cardinale et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation by the International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Applications of Cardiac Bio-Markers
Fred S. Apple et al.
CLINICAL CHEMISTRY (2021)
Biological Variation of Cardiac Troponins in Health and Disease: A Systematic Review and Meta-analysis
Jorge Diaz-Garzon et al.
CLINICAL CHEMISTRY (2021)
Clinical relevance of biological variation of cardiac troponins
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association
Kurt Ruetzler et al.
CIRCULATION (2021)
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Societa Italiana di Biochimica Clinica), and SIPMeL (Societa Italiana di Patologia Clinica e Medicina di Laboratorio)
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Cardiac troponins: are there any differences between T and I?
Marco A. Perrone et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2021)
Cardiovascular Aging and Longevity JACC State-of-the-Art Review
Panagiota Pietri et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Inflammatory markers and incident heart failure in older men: the role of NT-proBNP
Douglas G. J. McKechnie et al.
BIOMARKERS IN MEDICINE (2021)
Cardiac Aging: From Basic Research to Therapeutics
Mingjing Yan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Revisited Upper Reference Limits for Highly Sensitive Cardiac Troponin T in Relation to Age, Sex, and Renal Function
Christiane Gaertner et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Role of Cardiac Biomarkers in Cancer Patients
Gennaro Carmine Semeraro et al.
CANCERS (2021)
Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
Olatunde Ola et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay
Fred S. Apple et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples
Vinajak Gopi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
High-sensitivity assay for cardiac troponins with POCT methods. The future is soon
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Diagnostic algorithms for non-ST-segment elevation myocardial infarction: open issues
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Inflammation-based assessment for the risk stratification of mortality in patients with heart failure
Tadashi Itagaki et al.
SCIENTIFIC REPORTS (2021)
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (vol 144, pg e368, 2021)
Martha Gulati et al.
CIRCULATION (2021)
Evaluation and Comparison with Other High-Sensitivity Methods of Analytical Performance and Measured Values of a New Laboratory Test for Cardiac Troponin I Assay
Silvia Masotti et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2021)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) (vol 42, pg 1289, 2021)
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Predicting mortality with cardiac troponins: recent insights from meta-analyses
Giuseppe Lippi et al.
DIAGNOSIS (2021)
Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay
Fred S. Apple et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples
Vinajak Gopi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) (vol 42, pg 1289, 2021)
Jean-Philippe Collet
EUROPEAN HEART JOURNAL (2021)
Myocardial injury after non-cardiac surgery: diagnosis and management
P. J. Devereaux et al.
EUROPEAN HEART JOURNAL (2020)
Gender-specific reference values for high-sensitivity cardiac troponin T and I in well-phenotyped healthy individuals and validity of high-sensitivity assay designation
Evangelos Giannitsis et al.
CLINICAL BIOCHEMISTRY (2020)
Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2-to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study
Richard M. Nowak et al.
ANNALS OF EMERGENCY MEDICINE (2020)
Targeting Age-Related Pathways in Heart Failure
Li Haobo et al.
CIRCULATION RESEARCH (2020)
High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population
Dimitrios Farmakis et al.
EUROPEAN HEART JOURNAL (2020)
Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects
Martina Zaninotto et al.
CLINICA CHIMICA ACTA (2020)
The European Biological Variation Study (EuBIVAS): weekly biological variation of cardiac troponin I estimated by the use of two different high-sensitivity cardiac troponin I assays
Ferruccio Ceriotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
Biniyam G. Demissei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I
Jasper Boeddinghaus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Early kinetic profiles of troponin I and T measured by high-sensitivity assays in patients with myocardial infarction
John W. Pickering et al.
CLINICA CHIMICA ACTA (2020)
Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Eleonora Cianflone et al.
CELLS (2020)
The combined measurement of high-sensitivity cardiac troponins and natriuretic peptides: a useful tool for clinicians?
Marco A. Perrone et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2020)
Inflammageing in the cardiovascular system: mechanisms, emerging targets, and novel therapeutic strategies
Danlin Liu et al.
CLINICAL SCIENCE (2020)
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from theCardio-Oncology Study Groupof theHeart Failure Associationand theCardio-Oncology Council of the European Society of Cardiology
Radek Pudil et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines
Joachim Alexandre et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Harmonization of two hs-cTnI methods based on recalibration of measured quality control and clinical samples
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2020)
Cardiotoxicity of Anthracyclines
Daniela Cardinale et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
A Possible Mechanism behind Faster Clearance and Higher Peak Concentrations of Cardiac Troponin I Compared with Troponin T in Acute Myocardial Infarction
Karin Starnberg et al.
CLINICAL CHEMISTRY (2020)
Myocardial injury after non-cardiac surgery: diagnosis and management
P. J. Devereaux et al.
EUROPEAN HEART JOURNAL (2020)
High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population
Dimitrios Farmakis et al.
EUROPEAN HEART JOURNAL (2020)
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples
Veronica Musetti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
High-sensitivity troponin I for cardiovascular risk stratification in the general asymptomatic population: Perspectives from Asia-Pacific
Carolyn S. P. Lam et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Cardiac Troponin T and Troponin I in the General Population Comparing and Contrasting Their Genetic Determinants and Associations With Outcomes
Paul Welsh et al.
CIRCULATION (2019)
Evaluation of 99th percentile and reference change values of a high-sensitivity cTnI method: A multicenter study
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2019)
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
Christian Mueller et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Evaluation of reproducibility of the cTnT immunoassay using quality control samples
Rudina Ndreu et al.
CLINICA CHIMICA ACTA (2019)
Evaluation of 99th percentile and reference change values of the hs-cTnI method using ADVIA Centaur XPT platform: A multicenter study
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2019)
Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: A multi-center study
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2019)
Cardiomyocyte damage control in heart failure and the role of the sarcolemma
Ashraf Kitmitto et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2019)
Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay
Nils A. Soerensen et al.
CLINICAL CHEMISTRY (2019)
High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers
Paul O. Collinson et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
HIGH-SENSITIVITY CARDIAC TROPONIN AND THE FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION
Andrew Chapman et al.
HEART (2019)
Fourth universal definition of myocardial infarction (2018)
Kristian Thygesen et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2019)
Point-of-care testing in primary care patients with acute cardiopulmonary symptoms: a systematic review
Angel M. R. Schols et al.
FAMILY PRACTICE (2018)
Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trondelag Health [HUNT] Study)
Fjola D. Sigurdardottir et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Cardiovascular complications after non-cardiac surgery
D. Sellers et al.
ANAESTHESIA (2018)
One-year in vitro stability of cardiac troponins and galectin-3 in different sample types
Margot Egger et al.
CLINICA CHIMICA ACTA (2018)
Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction
Jasper Boeddinghaus et al.
CLINICAL CHEMISTRY (2018)
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine
Alan H. B. Wu et al.
CLINICAL CHEMISTRY (2018)
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I
Veronica Musetti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Personalized laboratory medicine: a patient-centered future approach
Irena Prodan Zitnik et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I
Silvia Masotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction
Raphael Twerenbold et al.
CIRCULATION (2018)
Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort
Paul Welsh et al.
CLINICAL CHEMISTRY (2018)
Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction
Raphael Twerenbold et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Luigi Ferrucci et al.
NATURE REVIEWS CARDIOLOGY (2018)
Point-of-Care Compatibility of Ultra-Sensitive Detection Techniques for the Cardiac Biomarker Troponin I-Challenges and Potential Value
Brian Regan et al.
BIOSENSORS-BASEL (2018)
How is cardiac troponin released from injured myocardium?
Johannes Mair et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Association of Repeatedly Measured High-Sensitivity Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study
Maria F. Hughes et al.
CLINICAL CHEMISTRY (2017)
Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care
Fred S. Apple et al.
CLINICAL CHEMISTRY (2017)
Variability of biomarkers in patients with chronic heart failure and healthy controls
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy
Daniela Cardinale et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery
P. J. Devereaux et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cellular Senescence: A Translational Perspective
James L. Kirkland et al.
EBIOMEDICINE (2017)
Circadian rhythm of blood cardiac troponin T concentration
Stephane Fournier et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition
Philip C. Calder et al.
AGEING RESEARCH REVIEWS (2017)
Twenty-Four-Hour Biological Variation Profiles of Cardiac Troponin I in Individuals with or without Chronic Kidney Disease
Noreen van der Linden et al.
CLINICAL CHEMISTRY (2017)
Cardiomyocyte Regeneration A Consensus Statement
Thomas Eschenhagen et al.
CIRCULATION (2017)
Statistical considerations for determining high-sensitivity cardiac troponin reference intervals
Peter E. Hickman et al.
CLINICAL BIOCHEMISTRY (2017)
Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium
Jack Marjot et al.
CLINICAL CHEMISTRY (2017)
Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery
Emmanuelle Duceppe et al.
CANADIAN JOURNAL OF CARDIOLOGY (2017)
Short- and Long-term Biologic Variability of Galectin-3 and Other Cardiac Biomarkers in Patients with Stable Heart Failure and Healthy Adults
Emily I. Schindler et al.
CLINICAL CHEMISTRY (2016)
Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T
Christian Mueller et al.
ANNALS OF EMERGENCY MEDICINE (2016)
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
Giuseppe Curigliano et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method High sensitive troponin I in pediatric age
Chiara Caselli et al.
CLINICA CHIMICA ACTA (2016)
The applied statistical approach highly influences the 99th percentile of cardiac troponin I
Kai M. Eggers et al.
CLINICAL BIOCHEMISTRY (2016)
Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations - A Systematic Review and Meta-analysis
Julie Sze et al.
HEART LUNG AND CIRCULATION (2016)
Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population A meta-analysis
Noreen van der Linden et al.
MEDICINE (2016)
Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm
Johannes Tobias Neumann et al.
JAMA CARDIOLOGY (2016)
Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention
Guillaume Laugaudin et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2016)
Dynamics of Cell Generation and Turnover in the Human Heart
Olaf Bergmann et al.
CELL (2015)
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy
Maria Franzini et al.
CLINICA CHIMICA ACTA (2015)
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2015)
Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction
Kamila Solecki et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I
Magdalena Krintus et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Anoop S. V. Shah et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Anoop S. V. Shah et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Biological variation of cardiac troponin T in patients with end-stage renal disease and in healthy individuals
Zoraida Corte et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2015)
Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician
Peter E. Hickman et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2015)
Myocardial Injury after Noncardiac Surgery A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes
Fernando Botto et al.
ANESTHESIOLOGY (2014)
The Global Need to Define Normality: The 99th Percentile Value of Cardiac Troponin
Yader Sandoval et al.
CLINICAL CHEMISTRY (2014)
Weekly and 90-Minute Biological Variations in Cardiac Troponin T and Cardiac Troponin I in Hemodialysis Patients and Healthy Controls
Kristin M. Aakre et al.
CLINICAL CHEMISTRY (2014)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)
Steen Dalby Kristensen et al.
EUROPEAN HEART JOURNAL (2014)
The Intersection Between Aging and Cardiovascular Disease
Brian J. North et al.
CIRCULATION RESEARCH (2012)
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study
Aldo Clerico et al.
CLINICA CHIMICA ACTA (2012)
Long-term biological variation in cardiac troponin I
Alan H. B. Wu et al.
CLINICAL BIOCHEMISTRY (2012)
Influence of Population Selection on the 99th Percentile Reference Value for Cardiac Troponin Assays
Paul O. Collinson et al.
CLINICAL CHEMISTRY (2012)
Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery
P. J. Devereaux et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide
Mauro Feola et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Daniela Cardinale et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Troponin Elevation in Heart Failure Prevalence, Mechanisms, and Clinical Implications
Robb D. Kociol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Short- and Long-Term Biological Variation in Cardiac Troponin I Measured with a High-Sensitivity Assay: Implications for Clinical Practice
Alan H. B. Wu et al.
CLINICAL CHEMISTRY (2009)
Short- and Long-Term Cardiac Troponin I Analyte Stability in Plasma and Serum from Healthy Volunteers by Use of an Ultrasensitive, Single-Molecule Counting Assay
Alan H. B. Wu et al.
CLINICAL CHEMISTRY (2009)
A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population.
Alex B. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Evidence for Cardiomyocyte Renewal in Humans
Olaf Bergmann et al.
SCIENCE (2009)
Senescence-messaging secretome: SMS-ing cellular stress
Thomas Kuilman et al.
NATURE REVIEWS CANCER (2009)
Cardiomyocyte death and renewal in the normal and diseased heart
Louis Maximilian Buja et al.
CARDIOVASCULAR PATHOLOGY (2008)
Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice
Simona Vittorini et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure
Michele Emdin et al.
CLINICAL CHEMISTRY (2007)
Reporting of cardiac troponin - Problems with the 99th population percentile
Peter E. Hickman et al.
CLINICA CHIMICA ACTA (2007)
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
Daniela Cardinale et al.
CIRCULATION (2006)
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence
Jean-Philippe Coppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
A Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
SA Hunt et al.
CIRCULATION (2005)
Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
